Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.68 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14302420 | 1.00 | SLC5A2 (0.68) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL3936832 | 1.00 | SLC5A2 (0.68) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL14278453 | 1.00 | SLC5A2 (0.68) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL1585185 | 0.91 | SLC5A2 (0.80) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL154723 | 0.91 | SLC5A2 (0.80) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL14302213 | 0.91 | SLC5A2 (0.80) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL14278452 | 0.86 | SLC5A2 (0.67) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL3943610 | 0.86 | SLC5A2 (0.67) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL14302395 | 0.86 | SLC5A2 (0.67) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 | |
| SCHEMBL14278451 | 0.85 | SLC5A2 (0.68) | SLC5A2SLC5A1ABCB11ADORA3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008013321-A1 | NOVEL SGLT INHIBITORS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-01-31 | — | — | WO | disclosed |